This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers insights across biomanufacturing, targeted drug delivery, imaging, precision medicine and biologics innovations.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Nanofiber Microcarriers, Viral Vector, Biomanufacturing, Cell and Gene Therapy, Precision Medicine, Genomics, Myelin Restoration, Neurological Repair, CRISPR, AI-powered Target Discovery, Genome Editing, TdT-dNTP Conjugates, Epigenetic Therapy, Multispecific Antibody, Infectious Disease, Oncology, Drug Delivery, Nucleic Acid-based Therapies, Viral Vector, Non-viral Vector, Oligonucleotide Therapy, AAV8-based Gene Therapy, Neurological Disease, T-cell Engager, Radiographic Image, Gene Expression, Metastatic Colorectal Cancer, Isothermal Diagnostics, Metagenomics, Liquid Biopsy